Case Study Event in NYC Reveals 98% Accuracy in Predicting Ovulation with KNOWHEN® Fertility Monito

NEW YORK - July 28, 2014 - PRLog -- MEDIA ADVISORY

Case Study Event in NYC to Reveal 98% Accuracy in Predicting Ovulation with KNOWHEN® Fertility Monitor
Saliva Tells All!

Hugh Melnick, MD, Director of the Advanced Fertility Clinic in NYC will share information on studies he is publishing that can change the lives of women around the globe

The ability to predict periods of fertility is of great important to women, both as a means of contraception and as a way to facilitate conception.  Dr. Melnick conducted studies to evaluate the efficacy and accuracy of the KNOWHEN® Saliva Fertility Monitor with Education and Free App as a predictor of ovulation.

Dr. Melnick, a graduate of the University of Pennsylvania and Temple University Medical School used a STUDY POPULATION of twenty two healthy women, aged 22-40, having regular menstrual cycles between 26 and 34 days.  Women who were taking hormonal medication or who were smokers were excluded from this study.


On Wednesday, July 30th from 5 -7 PM, Dr. Melnick will discuss the methods used as well as the results which indicate that there was a close correlation between actual ovulation as determined by his testing methods and the KNOWHEN® Fertility Monitor

WHO:   Dr. Hugh Melnick, Director of the Advanced Fertility Clinic, 1625 3rd Ave., NYC

WHAT:  Case Study Event to discuss his findings on the efficacy and accuracy of the KNOWHEN® Fertility Monitor

WHEN:  July 30th 5-7pm

WHERE:   Cucina Ciano Italian Restaurant, 181 E. 78th Street, NY, 10075

DETAILS:  If you are interested in the case studies, the findings or are in the medical field, are fertility focused or part of the healthcare or business media and want to hear from Dr. Melnick himself. Helen Denise, CEO and Founder of Hilin Life Products, Inc. will be on hand to meet you and answer any questions you have along with Dr. Hugh Melnick.